Utivac Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.50 Cr
as on 16-11-2024
- Revenue 15.47%
(FY 2023)
- Profit 91.77%
(FY 2023)
- Ebitda -33.94%
(FY 2023)
- Net Worth 38.17%
(FY 2023)
- Total Assets 32.36%
(FY 2023)
About Utivac Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹15.00 Cr. The company has closed loans amounting to ₹7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vivek Tiwari, Vijay Subramaniam, and Ketan Malkan serve as directors at the Company.
- CIN/LLPIN
U51909KA2018PTC113856
- Company No.
113856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Utivac Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ketan Malkan  | Director | 01-Oct-2022 | Current |
| Vivek Tiwari | Director | 01-Oct-2022 | Current |
| Vijay Subramaniam | Director | 11-Jun-2018 | Current |
Financial Performance of Utivac Healthcare.
Utivac Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.47% increase. The company also saw a substantial improvement in profitability, with a 91.77% increase in profit. The company's net worth Soared by an impressive increase of 38.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Utivac Healthcare?
In 2023, Utivac Healthcare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Boston Ivy Healthcare Solutions Private LimitedActive 11 years 6 monthsVivek Tiwari is a mutual person
Aushadhiv Specialty Pharmaceuticals Private LimitedActive 2 years 5 monthsVivek Tiwari and Ketan Malkan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Dec 2020 | ₹15.00 Cr | Open |
Axis Bank Limited Creation Date: 03 Nov 2018 | ₹7.50 Cr | Satisfied |
How Many Employees Work at Utivac Healthcare?
Unlock and access historical data on people associated with Utivac Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Utivac Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Utivac Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
